View Menu Hide Menu

Recent publications and conference presentations from VHsquared include:

Preclinical assessment of a novel anti-TNFα Vorabody™ as an oral therapy for Crohn’s Disease

18th International Congress of Mucosal Immunology, July 19-22 2017, Washington DC, USA

 

 

Oral delivery of a novel domain antibody (Vorabody™) for the treatment of Crohn’s Disease

Global Conference on Pharmaceutics and Drug Delivery Systems, June 29 – July 1 2017, Valencia Spain

 

 

Gastrointestinal Stability and Tissue Penetration of V565:
A Novel Orally Administered Anti-TNFα Vorabody™

10th Annual Proteins and Antibodies Congress, April 24-25 2017, London UK